{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:52:52Z","timestamp":1789087972525,"version":"build-2803163510"},"reference-count":51,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Technology Major Project of China","award":["2018ZX09301030-005"],"award-info":[{"award-number":["2018ZX09301030-005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease with a global prevalence of 25%. However, the medicines approved by the FDA or EMA are still not commercially available for the treatment of NAFLD. The NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) inflammasome plays a crucial role in inflammatory responses, and the mechanisms related to steatohepatitis have been sufficiently clarified. NLRP3 has been widely evaluated as a potential target for multiple active agents in treating NAFLD. As a quercetin glycoside, isoquercitrin (IQ) has a broad inhibitory effect on oxidative stress, cancers, cardiovascular diseases, diabetes, and allergic reactions in vitro and in vivo. This study aimed to investigate the undercover mechanism of IQ in the treatment of NAFLD, particularly in anti-steatohepatitis, by suppressing the NLRP3 inflammasome. In this study, a methionine-choline-deficient induced steatohepatitis mice model was used to explore the effect of IQ on NAFLD treatment. Further mechanism exploration based on transcriptomics and molecular biology revealed that IQ inhibited the activated NLRP3 inflammasome by down-regulating the expression of heat shock protein 90 (HSP90) and suppressor of G-two allele of Skp1 (SGT1). In conclusion, IQ could alleviate NAFLD by inhibiting the activated NLRP3 inflammasome by suppressing the expression of HSP90.<\/jats:p>","DOI":"10.3390\/ijms24108795","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T02:37:51Z","timestamp":1684204671000},"page":"8795","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4608-3908","authenticated-orcid":false,"given":"Ji","family":"Ma","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoru","family":"Li","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Deng","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Ding","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China"},{"name":"Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Eslam, M., Sanyal, A.J., and George, J. (2020). International Consensus Panel MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology, 158.","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Younossi, Z., Stepanova, M., Ong, J.P., Jacobson, I.M., Bugianesi, E., Duseja, A., Eguchi, Y., Wong, V.W., Negro, F., and Yilmaz, Y. (2019). Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc., 17.","DOI":"10.1016\/j.cgh.2018.05.057"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","article-title":"Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-Induced Mouse Model through Tumor Necrosis Factor-\u03b1 Production","volume":"287","author":"Landes","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-Mediated Dysbiosis Regulates Progression of NAFLD and Obesity","volume":"482","author":"Elinav","year":"2012","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome Activation and Function in Liver Disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in Liver Diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"678627","DOI":"10.1155\/2013\/678627","article-title":"The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders","volume":"2013","author":"Benetti","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2014.5994","article-title":"Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?","volume":"22","author":"Abais","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 Inflammasome Activation Is Required for Fibrosis Development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yu, L., Hong, W., Lu, S., Li, Y., Guan, Y., Weng, X., and Feng, Z. (2022). The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.780496"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1517\/14728222.2013.789502","article-title":"Novel Therapeutic Targets for Nonalcoholic Fatty Liver Disease","volume":"17","author":"Eguchi","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ebrahimpour, S., Zakeri, M., and Esmaeili, A. (2020). Crosstalk between Obesity, Diabetes, and Alzheimer\u2019s Disease: Introducing Quercetin as an Effective Triple Herbal Medicine. Ageing Res. Rev., 62.","DOI":"10.1016\/j.arr.2020.101095"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.fct.2016.08.034","article-title":"Hepatoprotective Effect of Quercetin: From Chemistry to Medicine","volume":"108","author":"Miltonprabu","year":"2017","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.2174\/09298673113209990120","article-title":"Bioavailability of Quercetin: Problems and Promises","volume":"20","author":"Cai","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jn\/130.5.1200","article-title":"Bioavailabilities of Quercetin-3-Glucoside and Quercetin-4\u2019-Glucoside Do Not Differ in Humans","volume":"130","author":"Olthof","year":"2000","journal-title":"J. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0014-5793(97)01367-7","article-title":"Relative Bioavailability of the Antioxidant Flavonoid Quercetin from Various Foods in Man","volume":"418","author":"Hollman","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1017\/S000711451000053X","article-title":"Oral Bioavailability of Quercetin from Different Quercetin Glycosides in Dogs","volume":"104","author":"Reinboth","year":"2010","journal-title":"Br. J. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chagas, M.d.S.S., Behrens, M.D., Moragas-Tellis, C.J., Penedo, G.X.M., Silva, A.R., and Gon\u00e7alves-de-Albuquerque, C.F. (2022). Flavonols and Flavones as Potential Anti-Inflammatory, Antioxidant, and Antibacterial Compounds. Oxid. Med. Cell. Longev., 2022.","DOI":"10.1155\/2022\/9966750"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.fct.2014.03.018","article-title":"Isoquercitrin: Pharmacology, Toxicology, and Metabolism","volume":"68","author":"Vrba","year":"2014","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Qin, G., Ma, J., Huang, Q., Yin, H., Han, J., Li, M., Deng, Y., Wang, B., Hassan, W., and Shang, J. (2018). Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-\u03b2 Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19124126"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, Present and Future Perspectives in Nonalcoholic Fatty Liver Disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and Resolution of Inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Thomas, H. (2017). NAFLD: A Critical Role for the NLRP3 Inflammasome in NASH. Nat. Rev. Gastroenterol. Hepatol., 14.","DOI":"10.1038\/nrgastro.2017.21"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 Inflammasome Blockade Reduces Liver Inflammation and Fibrosis in Experimental NASH in Mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s10753-017-0628-z","article-title":"NLRP3 Deletion Inhibits the Non-Alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid","volume":"40","author":"Cai","year":"2017","journal-title":"Inflammation"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mangan, M.S.J., Olhava, E.J., Roush, W.R., Seidel, H.M., Glick, G.D., and Latz, E. (2018). Targeting the NLRP3 Inflammasome in Inflammatory Diseases. Nat. Rev. Drug Discov., 17.","DOI":"10.1038\/nrd.2018.97"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 Inflammasome: Molecular Activation and Regulation to Therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","article-title":"Anti-Inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome","volume":"285","author":"Juliana","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A Small-Molecule Inhibitor of the NLRP3 Inflammasome for the Treatment of Inflammatory Diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The Ketone Metabolite \u03b2-Hydroxybutyrate Blocks NLRP3 Inflammasome-Mediated Inflammatory Disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Daniels, M.J.D., Rivers-Auty, J., Schilling, T., Spencer, N.G., Watremez, W., Fasolino, V., Booth, S.J., White, C.S., Baldwin, A.G., and Freeman, S. (2016). Fenamate NSAIDs Inhibit the NLRP3 Inflammasome and Protect against Alzheimer\u2019s Disease in Rodent Models. Nat. Commun., 7.","DOI":"10.1038\/ncomms12504"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1002\/ptr.7104","article-title":"Quercetin as a Protective Agent for Liver Diseases: A Comprehensive Descriptive Review of the Molecular Mechanism","volume":"35","author":"Zhao","year":"2021","journal-title":"Phytother. Res. PTR"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"10194","DOI":"10.1021\/acs.jafc.2c03639","article-title":"Alternative to Sugar, Honey Does Not Provoke Insulin Resistance in Rats Based on Lipid Profiles, Inflammation, and IRS\/PI3K\/AKT Signaling Pathways Modulation","volume":"70","author":"Chen","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Wu, L., Zhang, Q., Mo, W., Feng, J., Li, S., Li, J., Liu, T., Xu, S., Wang, W., and Lu, X. (2017). Quercetin Prevents Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Reducing Autophagy via the TGF-\u03921\/Smads and PI3K\/Akt Pathways. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-09673-5"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and Functions of Inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The Inflammasome: A Molecular Platform Triggering Activation of Inflammatory Caspases and Processing of ProIL-Beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"21119","DOI":"10.1074\/jbc.C200179200","article-title":"The PYRIN-CARD Protein ASC Is an Activating Adaptor for Caspase-1","volume":"277","author":"Srinivasula","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.4049\/jimmunol.147.9.2964","article-title":"IL-1-Converting Enzyme Requires Aspartic Acid Residues for Processing of the IL-1 Beta Precursor at Two Distinct Sites and Does Not Cleave 31-KDa IL-1 Alpha","volume":"147","author":"Howard","year":"1991","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/386619a0","article-title":"Caspase-1 Processes IFN-Gamma-Inducing Factor and Regulates LPS-Induced IFN-Gamma Production","volume":"386","author":"Ghayur","year":"1997","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","article-title":"Activation of Interferon-Gamma Inducing Factor Mediated by Interleukin-1beta Converting Enzyme","volume":"275","author":"Gu","year":"1997","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wan, X., Xu, C., Yu, C., and Li, Y. (2016). Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH. Can. J. Gastroenterol. Hepatol., 2016.","DOI":"10.1155\/2016\/6489012"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Shi, Y., Su, W., Zhang, L., Shi, C., Zhou, J., Wang, P., Wang, H., Shi, X., Wei, S., and Wang, Q. (2020). TGR5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating NLRP3 Inflammasome Activation. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.609060"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"36617","DOI":"10.1074\/jbc.M112.407130","article-title":"Non-Transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation","volume":"287","author":"Juliana","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wu, D., Wu, K., Zhu, Q., Xiao, W., Shan, Q., Yan, Z., Wu, J., Deng, B., Xue, Y., and Gong, W. (2018). Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway. Mediat. Inflamm., 2018.","DOI":"10.1155\/2018\/3048532"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ni1459","article-title":"A Crucial Function of SGT1 and HSP90 in Inflammasome Activity Links Mammalian and Plant Innate Immune Responses","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/acer.14338","article-title":"Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol-Associated Liver Injury","volume":"44","author":"Choudhury","year":"2020","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lo, C.-W., Yen, C.-C., Chen, C.-Y., Chen, H.-W., and Lii, C.-K. (2023). Benzyl Isothiocyanate Attenuates Activation of the NLRP3 Inflammasome in Kupffer Cells and Improves Diet-Induced Steatohepatitis. Toxicol. Appl. Pharmacol., 462.","DOI":"10.1016\/j.taap.2023.116424"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/8795\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:35:32Z","timestamp":1760124932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/8795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24108795"],"URL":"https:\/\/doi.org\/10.3390\/ijms24108795","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]}}}